← Leaderboards
Christopher G Goetz
Rush University Medical Center
$591,438
Attributed
$1,552,314
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $926.4K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,552,314 · 2
By mechanism
U01$1,441,314 · 1
R21$111,000 · 1
Top collaborators
- Ali Keshavarzian3 shared
- Amol Sharma3 shared
Most similar at Rush University Medical Center
Same institution · by research overlap
- Francine Grodstein$20,315,113
- Garth R Swanson$4,371,742
- Bernardo Lemos$4,690,567
- David A Bennett$145,760,843
- Faraz Bishehsari$6,917,442
Others in their field
Top investigators on “Prognosis”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Charles A Coltman · Southwest Oncology Group$152,096,442
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Richard L Schilsky · University Of Chicago$118,916,917
- Norman Wolmark · Nsabp Foundation, Inc.$116,469,137
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
Research focus
PrognosisTissuesIntestinal BarrierPathologySamplingSymptomsFunctional DisorderInfrastructureMicrobiota-Gut-Brain AxisPathogenesisRecruitRepositoryBrainSeverity Of IllnessAlpha SynucleinCollaborationsBiological MarkersHouseholdDisease ProgressionMicrobiotaNational Institute Of Diabetes And Digestive And Kidney DiseasesParkinson DiseaseCohortUniversities
Grant awards (4)
The Bidirectional Gut-Microbiota-Brain Axis in Parkinsonâs disease: integrating mechanistic biomarkers of disease severity and progression$712,359
U01 · FY2025 · DK
The Bidirectional Gut-Microbiota-Brain Axis in Parkinsonâs disease: integrating mechanistic biomarkers of disease severity and progression$214,082
U01 · FY2025 · DK
The Bidirectional Gut-Microbiota-Brain Axis in Parkinsonâs disease: integrating mechanistic biomarkers of disease severity and progression$514,873
U01 · FY2024 · DK
Multiple Factors Affecting Placebo Response in PD$111,000
R21 · FY2004 · AT